Complimentary January 2022 JOPP issue for BOPA members

With the help of an educational grant from Novartis and in partnership with SAGE Publishing we are pleased to provide you with complimentary access to the January 2022 interactive issue of the Journal of Oncology Pharmacy Practice.

Access your cover to cover interactive issue of the Journal of Oncology Pharmacy Practice and keep up to date with pertinent case reports and consensus guidelines that drive clinical practice, in addition to information on new products, new therapies and patient management, as well as reviews of the latest research in cancer care pharmacy.

See below for the full URL link: https://www.nxtbook.com/nxteu/sageuk/opp_012022/

Latest News

By BOPA Research committee on 15th January 2026

Allied health and lifestyle support provision research survey

Dear members, Sheffield Hallam University’s Advanced Wellbeing Research Centre (AWRC) are working on behalf of Pfizer to identify the type of information, support and services offered to people living with metastatic…

Read article
By BOPA E&T Subcommittee on 15th January 2026

BOPA Introduction to Cancer Course, Scotland, March 2026 – LIMITED spaces available don’t miss out!

The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…

Read article
By BOPA E&T Subcommittee on 13th January 2026

Cancer Advanced and Consultant Pharmacist credentialing support series

As we head into 2026, BOPA is really pleased to share that the credentialing webinar support series from BOPA will continue in 2026. Through ongoing membership feedback, we’ve clearly identified…

Read article
By BOPA Research Committee on 26th December 2025

Optimising Medication in Older Adults Receiving Systemic Anticancer Therapies (SACT) – Research Study

We are inviting pharmacy professionals working in UK cancer services to take part in our study. What this research is about? To explore how pharmacy teams optimise medication for older…

Read article